Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
IPN:VIE
Ipsen SA
€163.90
+0.31%
(+0.50) 1D
Apr 28, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for IPN...
Open
€161.70
High
€164.00
Low
€161.70
Mkt. cap
13.89B
Avg. vol.
4.00
Volume
0.00
P/E ratio
30.81
52-wk high
€169.30
52-wk low
€98.35
EPS
€5.32
No. of employees
6K
News stories
From sources across the web
Profile
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
About Ipsen SA
CEODavid Loew
Employees5.54K
Founded1929
Headquarters-
SectorPharmaceutical industry
Websiteipsen.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
968.55M
968.55M
996.05M
996.05M
Cost of goods sold
162.55M
162.55M
212.90M
212.90M
Cost of revenue
162.55M
162.55M
212.90M
212.90M
Research and development expenses
182.45M
182.45M
194.55M
194.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
303.50M
303.50M
278.60M
278.60M
Operating expense
552.50M
552.50M
523.20M
523.20M
Total operating expenses
715.05M
715.05M
736.10M
736.10M
Operating income
253.50M
253.50M
259.95M
259.95M
Other non operating income
-12.05M
-12.05M
-7.35M
-7.35M
EBT including unusual items
212.50M
212.50M
76.55M
76.55M
EBT excluding unusual items
246.25M
246.25M
248.45M
248.45M
Income tax expense
44.75M
44.75M
22.05M
22.05M
Effective tax rate
21.06%
21.06%
28.80%
28.80%
Other operating expenses
66.55M
66.55M
50.05M
50.05M
Net income
167.00M
167.00M
54.75M
54.75M
Net profit margin
17.24%
17.24%
5.50%
5.50%
Earnings per share
-
-
-
-
Interest and investment income
5.75M
5.75M
8.25M
8.25M
Interest expense
-7.85M
-7.85M
-10.20M
-10.20M
Net interest expenses
-2.10M
-2.10M
-1.95M
-1.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
338.80M
338.80M
331.25M
331.25M
Gain or loss from assets sale
-300.00K
-300.00K
9.75M
9.75M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer